Study | Reason for exclusion |
---|---|
Soltan 2009 | Quasi‐RCT (alternate allocation) |
Soltan 2010 | Quasi‐RCT (alternate allocation) |
Gelany 2012 | This is an abstract for a PPH treatment study but there is insufficient information to permit 'Risk of bias' assessment. |
Letouzey 2013 | Study terminated due to recruitment difficulties. |
Mohamed 2014 | Abstract with insufficient information to assess risk of bias. |
Khalil 2014 | Abstract with insufficient information to assess risk of bias. Query whether this is report of Khalil 2011 but the limited outcome data do not match. Contacted trial author by email ‐ he replied confirming that this study is separate to Khalil 2011 trial. |
Nermeen 2015 | Prevention of PPH study |
Rahman 2015 | This was a trial of TempostatTM ‐ a self‐regulating tamponade device for management of postpartum haemorrhage (see NCT02416089). The trial was terminated. |
Purwosonu 2015 | Not an RCT. This is an open‐label non‐randomised trial |
Rezk 2016 | Prevention of PPH study |
Anger 2016 | This step‐wedge cluster‐RCT looked at a policy of introducing UBT into routine practice. 18 hospitals were randomised and the participants included women with PPH and without PPH. We have excluded this study because (1) it does not meet the inclusion criteria; and (2) does not give a sensitivity analysis of PPH women that could have been included. |
von Beckerath 2016 | Abstract with insufficient information to permit 'Risk of bias' assessment. We query whether this is part of Ali 2015a (ongoing) ‐ we have contacted the authors for clarification. |
Liu 2016 | Not a PPH treatment RCT ‐ comparison of 2 different nursing methods for women who had all had uterine embolisation for PPH |
Azmy 2016 | Prevention of PPH study |
Chen 2017 | Prevention of PPH study |
Sallam 2019 | Prevention of PPH study |
Farouk 2018 | Prevention of PPH study |
PPH: postpartum haemorrhage;RCT: randomised controlled trial; UBT: uterine balloon tamponade.